Inhibitor | VX-745  

Compound name Brutto MW CAS PubChem CID Action Reference Reference
VX-745   C19H9Cl2F2N3OS 436.26 209410-46-8 3038525 p38 MAPK Tsai YR Epub 2013 Jan 21 Eur J Pharmacol. 2013 Feb 15 701(1-3) 96-105

Screening Results Chart

Screening Results Tables

Screen Conc: 0.10µM
Kinase % Activity Remaining Standard Deviation
AMPK 100 3
Aurora B 99 18
BRSK2 94 11
BTK 98 7
CAMK1 93 17
CAMKK beta 110 4
CDK2-Cyclin A 101 17
CHK1 113 4
CHK2 106 3
CK1 delta 100 1
CK2 94 4
CSK 115 3
DYRK1A 101 11
DYRK2 108 0
DYRK3 104 0
EF2K 99 31
EPH-A2 123 5
EPH-B3 89 6
ERK1 103 0
ERK2 105 0
ERK8 111 26
FGF-R1 106 4
GCK 104 2
GSK3 beta 112 4
HER4 119 5
HIPK2 107 15
IGF-1R 115 4
IKK beta 98 8
IKK epsilon 105 3
IR 86 9
IRAK4 100 7
IRR 101 4
JNK1 114 19
JNK2 111 6
Lck 103 13
LKB1 96 3
MAPKAP-K2 107 2
MARK3 112 2
MELK 101 13
MINK1 120 2
MKK1 98 2
MLK1 91 3
MLK3 102 10
MNK1 75 1
MNK2 94 1
MSK1 91 6
MST2 132 16
MST4 103 1
NEK2a 111 1
NEK6 101 0
NUAK1 101 3
p38 alpha MAPK 17 6
p38 beta MAPK 66 8
p38 delta MAPK 119 24
p38 gamma MAPK 95 19
PAK4 107 4
PAK5 99 4
PAK6 96 9
PDK1 111 6
PHK 50 3
PIM1 101 16
PIM2 114 9
PIM3 100 13
PKA 103 9
PKB alpha 95 6
PKB beta 93 1
PKC alpha 102 9
PKC zeta 111 0
PKD1 112 19
PLK1 118 15
PRAK 96 8
PRK2 89 14
ROCK 2 96 4
RSK1 109 6
RSK2 85 4
S6K1 112 19
SGK1 127 21
SmMLCK 120 1
Src 93 9
SRPK1 106 9
SYK 114 0
TBK1 108 2
TTK 106 16
VEGFR1 117 2
YES1 103 3
Screen Conc: 1.00µM
Kinase % Activity Remaining Standard Deviation
AMPK 97 2
ASK1 105 12
Aurora A 98 7
Aurora B 88 0
BRSK1 103 3
BRSK2 87 8
BTK 102 1
CAMK1 104 8
CAMKK beta 89 5
CDK2-Cyclin A 110 2
CHK1 97 2
CHK2 107 6
CK1 delta 93 5
CK2 106 8
CLK2 81 8
CSK 99 5
DAPK1 86 5
DYRK1A 109 0
DYRK2 103 7
DYRK3 104 1
EF2K 90 1
EPH-A2 89 7
EPH-A4 106 11
EPH-B1 97 1
EPH-B2 94 13
EPH-B3 95 1
EPH-B4 92 2
ERK1 93 7
ERK2 100 15
ERK8 101 6
FGF-R1 105 9
GCK 96 4
GSK3 beta 91 4
HER4 99 6
HIPK1 98 1
HIPK2 91 0
HIPK3 102 2
IGF-1R 89 15
IKK beta 93 2
IKK epsilon 97 1
IR 108 8
IRAK4 81 5
IRR 83 2
JAK2 85 9
JNK1 89 6
JNK2 94 2
JNK3 92 6
Lck 101 11
LKB1 87 6
MAPKAP-K2 96 3
MAPKAP-K3 86 5
MARK1 95 2
MARK2 86 0
MARK3 93 0
MARK4 103 2
MEKK1 95 12
MELK 96 1
MINK1 107 15
MKK1 92 7
MKK2 93 2
MKK6 111 6
MLK1 104 1
MLK3 91 2
MNK1 124 1
MNK2 109 9
MSK1 89 3
MST2 96 2
MST4 92 3
NEK2a 83 3
NEK6 103 15
NUAK1 94 2
p38 alpha MAPK
5
1
p38 beta MAPK 28 5
p38 delta MAPK 77 3
p38 gamma MAPK 84 13
PAK2 98 10
PAK4 93 5
PAK5 94 1
PAK6 95 6
PDK1 93 3
PHK 114 0
PIM1 94 9
PIM2 108 5
PIM3 86 4
PKA 99 11
PKB alpha 87 3
PKB beta 91 7
PKC alpha 97 1
PKC zeta 99 3
PKD1 86 5
PLK1 99 12
PRAK 95 5
PRK2 84 10
RIPK2 102 5
ROCK 2 87 4
RSK1 104 1
RSK2 95 11
S6K1 92 10
SGK1 103 3
SmMLCK 83 3
Src 93 1
SRPK1 97 1
SYK 113 4
TAK1 89 3
TAO1 102 2
TBK1 94 6
TrkA 89 9
TTK 85 1
VEGFR1 100 12
YES1 95 4
Screen Conc: 10.00µM
Kinase % Activity Remaining Standard Deviation
AMPK 81 5
ASK1 106 13
Aurora A 103 2
Aurora B 85 9
BRSK1 106 2
BRSK2 88 11
BTK 84 11
CAMK1 86 5
CAMKK beta 86 0
CDK2-Cyclin A 106 3
CHK1 78 2
CHK2 90 6
CK1 delta 99 5
CK2 119 3
CLK2 76 15
CSK 89 7
DAPK1 80 10
DYRK1A 104 10
DYRK2 86 3
DYRK3 95 12
EF2K 84 3
EPH-A2 96 1
EPH-A4 103 4
EPH-B1 92 4
EPH-B2 97 11
EPH-B3 93 9
EPH-B4 95 4
ERK1 95 2
ERK2 84 1
ERK8 109 4
FGF-R1 116 14
GCK 98 2
GSK3 beta 83 3
HER4 99 1
HIPK1 101 2
HIPK2 97 7
HIPK3 102 7
IGF-1R 103 5
IKK beta 95 4
IKK epsilon 95 7
IR 88 15
IRAK4 88 0
IRR 105 7
JAK2 101 7
JNK1 93 2
JNK2 84 7
JNK3 91 1
Lck 89 1
LKB1 93 0
MAPKAP-K2 94 7
MAPKAP-K3 89 2
MARK1 84 4
MARK2 92 4
MARK3 98 2
MARK4 96 3
MEKK1 96 5
MELK 87 8
MINK1 95 3
MKK1 86 7
MKK2 71 1
MKK6 104 4
MLK1 97 6
MLK3 85 10
MNK1 94 2
MNK2 97 7
MSK1 86 2
MST2 95 12
MST4 98 1
NEK2a 85 2
NEK6 97 11
NUAK1 89 4
p38 alpha MAPK
4
0
p38 beta MAPK 20 2
p38 delta MAPK 89 3
p38 gamma MAPK 82 5
PAK2 93 6
PAK4 91 9
PAK5 80 2
PAK6 83 14
PDK1 91 1
PHK 116 3
PIM1 91 8
PIM2 105 4
PIM3 80 3
PKA 90 4
PKB alpha 98 6
PKB beta 91 7
PKC alpha 97 6
PKC zeta 106 6
PKD1 96 7
PLK1 106 5
PRAK 95 5
PRK2 89 6
RIPK2 110 12
ROCK 2 80 6
RSK1 104 3
RSK2 78 1
S6K1 90 6
SGK1 100 12
SmMLCK 74 5
Src 92 15
SRPK1 95 7
SYK 99 2
TAK1 91 10
TAO1 83 3
TBK1 89 7
TrkA 89 11
TTK 97 1
VEGFR1 80 12
YES1 91 6